evoke semaglutide trial In December 2023, the FDA approved the first CRISPR therapy for humans. Patients with sickle cell disease, a disease that has shortened lives for centuries, are now functionally cured. The clinic of Two phase 3 trials testing
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9

























